A study to find out how efficacious is single injection of Omalizumab (a biologic drug to treat long standing urticaria) in treating long standing urticaria (HIVES)
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Diagnosed cases of urticaria on treatment not getting relief with conventional treatment will be given Omalizumab injection an approved drug for the same
- Registration Number
- CTRI/2017/11/010672
- Lead Sponsor
- Command Hospital Air Force
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 37
Inclusion Criteria
All patients reported to Dermatology department of CHAF Bangalore and were diagnosed as a case of chronic spontaneous urticaria (characterized by itchy hives that occur for at least six weeks with or without angioedema but have no apparent trigger) eliminating all possible causes for urticaria after through history taking and investigations and were symptomatic with moderate to severe urticaria (UAS-7 >15) even after double the dose of anti-histamines (Tab Fexofenadine 360 mg)comprised the study group.
Subjects who were willing and able to comply with all follow-up requirements
Exclusion Criteria
Clearly defined underlying cause of urticaria
Patient previously treated with Omalizumab
History of malignancy
Pregnancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method